Research Article
Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke
Table 1
Clinical characteristics of groups I and II.
| Clinical feature | Group I () | Group II () | |
| Qualitative parameters | (%) | (%) | value | Male gender | 20 (46.5) | 10 (45.5) | 0.9227 | Sever clinical status | | | | NIH ≤ 7 (%) | 17 (39.6) | — | | NIH 8–17 | 13 (30.2) | — | | NIH > 18 | 13 (30.2) | — | | Neurological status improvement | | | | No improvement | 16 (37.2) | — | | Improvement < 50% | 13 (30.2) | — | | Improvement > 50% or complete recovery | 14 (32.6) | — | | Death | 3 (7.0) | — | | Hypertension | 43 (100) | 20 (90.9) | 0.2100 | Dyslipidemia | 17 (39.6) | 7 (31.8) | 0.5419 | Diabetes mellitus | 15 (34.9) | 6 (27.2) | 0.5347 | Current smoking | 8 (18.6) | 4 (18.2) | 0.9328 | Excessive alcohol intake | 8 (18.6) | 3 (13.6) | 0.5858 | Obesity | 11 (25.6) | 4 (18.2) | 0.5029 | Overweight | 20 (46.5) | 7 (31.8) | 0.2553 | Coronary artery disease | 23 (53.5) | 7 (31.8) | 0.0973 | Atrial fibrillation | 16 (37.2) | 6 (27.2) | 0.4231 | ACE inhibitors | 33 (76.7) | 13 (59.1) | 0.1387 | Aspirin | 18 (41.9) | 8 (36.4) | 0.1387 | Enoxaparin | 2 (4.7) | 1 (4.5) | 0.9847 | Quantitative parameters | Mean ± SD | Mean ± SD | value | Age (y) | 75.2 ± 11.3 | 72.6 ± 9.3 | 0.1553 | Plasma hsCRP (mg/L) | 8.2 ± 18.3 | 3.0 ± 7.6 | 0.0322 | Plasma fibrinogen (mg/dL) | 378.3 ± 91.5 | 360 ± 67.6 | 0.2517 | White blood cells (WBC) (G/L) | 9.5 ± 3.21 | 6.6 ± 2.01 | 0.5723 | Plasma total homocysteine (μmol/L) | 14.2 ± 8.8 | 12.0 ± 6.1 | 0.4969 | Lipid profile (mg/dl) | | | | Total cholesterol | 178.2 ± 44.2 | 176.1 ± 41.1 | 0.9117 | LDL cholesterol | 111.0 ± 39.4 | 101 ± 31.2 | 0.3494 | HDL cholesterol | 45.5 ± 13.7 | 39 ± 11.2 | 0.1344 | Triglycerides | 113.3 ± 40.2 | 99 ± 30.2 | 0.3050 |
|
|
Chi-squared test. Mann–Whitney U test. |